AIDS conference: COVID-19, big breakthroughs and missed targets
1 Mins read
Reading Time: < 1 minute This year saw the first ever AIDS conference to be held entirely online. Read More
Gilead: Remdesivir Is Not The Only Reason To Buy
1 Mins read
Reading Time: < 1 minute Over the past three months, Gilead Sciences has entered the public consciousness due to the use of its drug Remdesivir to treat…
Treatment Adherence, Viral Suppression Suffer Due to HIV-Related Stigma in Florida
1 Mins read
Reading Time: < 1 minute Stigma perpetuated in a health care setting, compared with generalized stigmatization, has been linked to greater odds of poor outcomes in the…
COVID-19, the aftermath: insights from history
1 Mins read
Reading Time: < 1 minute Racial and class-based divisions, economic strife and extreme politics have all followed pandemics in history, Read More
Phone-based HIV support system repurposed for COVID-19 monitoring in Uganda
1 Mins read
Reading Time: < 1 minute People entering Uganda have been required to quarantine for 14 days as part of the country’s lockdown measures, Read More
Gambia: Witness Claims Jammeh Lied About HIV/Aids Treatment
1 Mins read
Reading Time: < 1 minute The TRRC protected witness who yesterday testified alleged that former President Yahya Jammeh had lied about his claims of HIV/AIDS treatment. …
PEPFAR opens media training on HIV and AIDS
1 Mins read
Reading Time: < 1 minute The United States (US) Embassy under the Presidents’ Emergency Fund for AIDS Relief (PEPFAR), on Tuesday, held a virtual launch of a…
HIV Antiviral Expanded for Use in Very Young Children
1 Mins read
Reading Time: < 1 minute The FDA expanded use of the HIV antiviral dolutegravir to treat children aged 4 weeks or older who weigh at least 3…
Ghana Faces Anti-Retroviral Shortages - NSA-Ghana
1 Mins read
Reading Time: < 1 minute The Non-State Actors for Health and Development (NSA-Ghana) has appealed to the Government, to as a matter of urgency, Read More